beta-D-Glcp3,6Me2-(1->4)-alpha-L-Rhap2,3Me2-(1->2)-alpha-L-Rhap3Me

Term ID

CHEBI:59469

Synonyms

3,6-di-O-methyl-beta-D-glucopyranosyl-(1->4)-2,3-di-O-methyl-alpha-L-rhamnopyranosyl-(1->2)-3-O-methyl-alpha-L-rhamnopyranose
3,6-di-O-methyl-beta-D-glucopyranosyl-(1->4)-6-deoxy-2,3-di-O-methyl-alpha-L-mannopyranosyl-(1->2)-6-deoxy-3-O-methyl-alpha-L-mannopyranose
3,6-di-O-methyl-beta-D-glucosyl-(1->4)-2,3-di-O-methyl-alpha-L-rhamnosyl-(1->2)-3-O-methyl-alpha-L-rhamnose
beta-D-Glc3,6Me2-(1->4)-alpha-L-Rha2,3Me2-(1->2)-alpha-L-Rha3Me
Glc3,6Me2beta1-4Rha2,3Me2alpha1-2Rha3Mealpha
Mycobacterium leprae PGL-1 trisaccharide

Definition

A linear trisaccharide derivative consisting of a 3,6-di-O-methylglucose residue linked to a 2,3-di-O-methylrhamnosyl-(1->2)-3-O-methylrhamnose unit.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: trisaccharide derivative

trisaccharide derivative Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-Glcp3,6Me2-(1->4)-alpha-L-Rhap2,3Me2-(1->2)-alpha-L-Rhap3Me

Phenotype where environments contain beta-D-Glcp3,6Me2-(1->4)-alpha-L-Rhap2,3Me2-(1->2)-alpha-L-Rhap3Me

Phenotype modified by environments containing beta-D-Glcp3,6Me2-(1->4)-alpha-L-Rhap2,3Me2-(1->2)-alpha-L-Rhap3Me

Human Disease Model